Development of the Anemia Impact Measure (AIM): A Disease-Specific Patient Reported outcome (PRO) Instrument to Measure Anemia Symptoms and Their Impact on Functioning in Cancer Patients Receiving Chemotherapy Kleinman, L., Benjamin, K., Viswanathan, H., Mattera, M., Bosserman, L. D., Blayney, D. W., Revicki, D. AMER SOC HEMATOLOGY. 2008: 250

View details for Web of Science ID 000262104700669